Wnt factors regulate neural stem cell development and neuronal connectivity. Here we investigated whether Wnt-3a and Wnt-3, expressed in the developing spinal cord, regulate proliferation and the neuronal differentiation of spinal cord neural precursors (SCNP). Wnt-3a promoted a sustained increase of SCNP proliferation, whereas Wnt-3 enhanced SCNP proliferation transiently and increased neurogenesis through β-catenin signaling. Consistent with this, Wnt-3a and Wnt-3 differently regulate the expression of Cyclin-dependent kinase inhibitors. Furthermore, Wnt-3a and Wnt-3 stimulated neurite outgrowth in SCNP-derived neurons through ß-catenin and TCF4-dependent transcription. GSK-3ß inhibitors mimicked Wnt signaling and promoted neurite outgrowth in established cultures. We conclude that Wnt-3a and Wnt-3 signal through the canonical Wnt/β-catenin pathway to regulate different aspects of SCNP development. These findings may be of therapeutic interest for the treatment of neurodegenerative diseases and nerve injury.
and Wnt-3a control spinal cord dorsal interneuron specification (Murashov et al. 2005; Muroyama et al. 2002) . Different Wnts distinctly regulate proliferation and neurogenesis of developing midbrain NPs (Andersson et al. 2008; Castelo-Branco et al. 2003; Hirabayashi et al. 2004; Sousa et al. 2009 ). Wnt-7a directs the neuronal differentiation of cortical NPs (Hirabayashi et al. 2004 ). In addition, Wnt-3 regulates neurogenesis and Wnt-7a stimulates NP self-renewal and proliferation in the adult brain (Lie et al. 2005; Qu et al.) .
Wnts signal through three main pathways: the canonical Wnt/ß-catenin, the planar cell polarity and the calcium pathways (Ciani and Salinas 2005; Logan and Nusse 2004; Michaelidis and Lie 2008) . In the canonical pathway, Wnts inhibit GSK-3ß, resulting in ß-catenin cytoplasmic stabilization, translocation to the nucleus and transcription by TCF/Lef factors of target genes. It is well documented that ß-catenin controls the expansion of NP populations through TCF activity (Chenn and Walsh 2002; Gulacsi and Anderson 2008; Zechner et al. 2003) . Thus ß-catenin stabilization results in enlarged brain and spinal cord, whereas loss of ß-catenin reduces brain size and increases neuronal differentiation (Gulacsi and Anderson 2008; Woodhead et al. 2006) . In agreement with these findings, the dorsal neural tube is reduced in size in Wnt-1/Wnt-3a mutant mice (Ikeya et al. 1997) . In contrast, ß-catenin F o r P e e r R e v i e w 4 stabilization increases neuronal differentiation of embryonic stem cells and NP (Castelo-Branco et al. 2004; Hirabayashi et al. 2004; Otero et al. 2004) . Therefore, activation of the Wnt/ß-catenin signaling regulates proliferation and neuronal differentiation of NP highly depending on the cellular context and the developmental stage (Hirabayashi et al. 2004 ).
Wnt-3a and Wnt-3 are expressed at dorsal areas of the developing spinal cord (Megason and McMahon 2002; Parr et al. 1993) . Interestingly, Wnt-3 is also expressed around the ventricular zone as well as by lateral motoneurons (Krylova et al. 2002; Megason and McMahon 2002) . It was proposed that dorsal Wnt-1 and Wnt-3a display mitogenic activities that shape the growth of the spinal cord (Megason and McMahon 2002) . Here we investigated the roles of Wnt-3a and Wnt-3 factors in spinal cord neural precursor (SCNP) development. We found that both Wnt-3a and Wnt-3 promoted SCNP proliferation. Contrary to the mitogenic effect of Wnt-3a, Wnt-3 increased SCNP proliferation only transiently and enhanced neurogenesis. Furthermore, Wnt-3a and
Wnt-3 stimulated neurite outgrowth. GSK-3ß inhibitors promoted or reduced neurite extension depending on the stage of neurite outgrowth, suggesting distinct roles of GSK-3ß during neurite development. Finally, ß-catenin and transcription by TCF4 were required for neurogenesis and neurite outgrowth induced by Wnts. These findings identify a role for canonical Wnt/ß-catenin signaling in SCNP-derived neuronal differentiation (including neurogenesis and neurite extension). Our results uncover similar actions of Wnt-3a and Wnt-3 during neurite outgrowth and a distinct regulation of cell cycle entry/exit by Wnt factors in SCNP proliferation/neurogenesis. 
MATERIAL AND METHODS
Spinal cord neural precursor (SCNP) culture. Mouse embryonic day 12.5-13 spinal cords were dissociated, after cleaning off the meninges, in phosphate buffer saline (PBS) plus 0.6% glucose using Pasteur pipettes (Wu et al. 2003 (20 µg/ml; Santa Cruz;) together with Wnt-3 CM showed a blockade of the effects induced by Wnt-3 CM (data not shown), indicating that they were due to Wnt-3.
Cell treatments. SCNP were stimulated with 50 ng/ml Bovine Serum Albumin (BSA), 50 ng/ml Wnt-3a (R&D), control CM or Wnt-3 CM from the time of plating for 2-4 days in vitro (DIV). The effect of Wnt-3a (50 ng/ml) was maintained within the 5-200 F o r P e e r R e v i e w 6 ng/ml range. Kenpaullone (Sigma; 15 µM) and BIO (6-bromoindirubin-3-oxime, Calbiochem; 1µM) were added from plating (DIV0-3) or from day 2 to day 3 (DIV2-3) and cultures were fixed at 3DIV. Actinomycin D (ActD, 5nM; Sigma) was added from plating and cultures fixed at 2DIV. Recombinant mouse Frizzled-8 cystein-rich domain/Fc chimera and Dikkopf-1 (R&D) were incubated at 100 or 300 ng/ml together with BSA, Wnt-3a, control CM or Wnt-3 CM from plating up to 4 DIV. All media was changed every other day, except for control and Wnt-3 CM that were changed daily.
Flow cytometry analysis (FACS)
. SCNP stimulated with BSA/Wnt-3a or control/Wnt-3 CM for 2DIV were trypsinized and fixed by resuspension in PBS and 70% ethanol (2 hours, 4°C). Cells were incubated with 0.1% Triton X-100, 50 µg/ml of propidium iodide and 50 µg/ml of RNAse A (all from Sigma; 30 min, 37°C) before DNA content analysis on EPICS-XL flow cytometer (Coulter).
Real time RT-PCR.
Total RNA was isolated from SCNP cultures treated with BSA, Wnt-3, control or Wnt-3 CM up to 4DIV using the RNAeasy kit (Qiagen) including the DNAse digestion step. For reverse transcription, 0,5-1 µg of RNA was incubated 2 min at 90°C and the reaction was performed in 6.25 mM MgCl 2 , 2 mM dNTPs mix, 2.5 mM random hexamers, 20 U of RNAse inhibitor and 50 U of Multiscribe™ (all from Applied Biosystems; 10 min, 25°C/60 min, 42°C/5min, 95°C). RT-control samples were run in paral.lel without the addition of reverse transcriptase. Real-time RT-PCR was performed in triplicate using 1 µl of cDNA or RT-sample, Taqman Master Mix™ (Applied Biosystems) and FAM-labeled probes spanning different exons specific for mouse p57 (Mm00438170_m1), p27 (Mm00438168_m1) and β-actin (4352933E) as a housekeeping gene in a ABI Prism 7000 detection system (Applied Biosystems; 2 min, 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 shRNA expression by lentiviral infection. Specific 19 nucleotide sequences were chosen using RNAi design interfaces. Primers were designed against the sequences GGGTTCTGATGATATAAAT (shRNA1) and GTTTGTGCAGTTGCTTTAT (shRNA2) for mouse ß-catenin and cloned into pSUPER. A fragment containing the H1 promoter for the RNA pol III and the shRNA sequence was subcloned into the pLVTHM plasmid (from Dr. D. Trono, Geneva). shRNA vectors were transfected into HEK293T together with psPAX2 and pMD2G and the viral pellet was obtained (David et al. 2008) . Transfection efficiency (~ 90%) was analyzed by GFP expression driven by pLVTHM. SCNP were transduced with lentivirus expressing shRNAs 2 hours after plating and treated with BSA, Wnt-3a, control or Wnt-3 CM from 3DIV to 5DIV. Cells were fixed for GFP/ßIII-tubulin immunostaining and analyzed for neurogenesis or neurite outgrowth at 5DIV. Alternatively, cultures were lysed in 62.5 mM Tris-HCl, pH 6,8 and 2% SDS for Western-blot.
Nucleofection. Expression of EGFP alone or dominant-negative ∆N-TCF4-HA plus EGFP (3:1) was achieved using the Nucleofector (Amaxa) upon neurosphere disgregration. SCNP were sub-plated at 300 cells/mm 2 , treated 4 hours after plating with Wnts, fixed at 2DIV and immunostained for EGFP and HA (only cells coimmunostained were measured for neurite length using the EGFP immunostaining 
RESULTS

Wnt-3a and Wnt-3 increase SCNP proliferation
The expression patterns of Wnt-3a and Wnt-3 in the developing spinal cord (Krylova et al. 2002; Megason and McMahon 2002; Parr et al. 1993 ) prompted us to study and Wnt-3 signaling in mouse SCNP cultures. Since purified Wnt-3 is not available, we used CMs obtained from Rat1B-cells stably expressing Wnt-3 or control cells (Krylova et al. 2002; Purro et al. 2008 ). We first investigated a possible effect of Wnt-3a/Wnt-3 in SCNP proliferation by FACS analysis. Wnt-3a and Wnt-3 treatments increased the percentage of cells in S phase compared to the corresponding control by 29% and 41% at 2DIV after 48h of Wnt stimulation (Fig. 1A) . We also performed BrdU incorporation assays in SCNP cultures co-immunostained for nestin. Nestin immunostaining revealed heterogeneous morphologies of SCNP (Fig. 1B) . Therefore, we calculated the percentage of cells that incorporated BrdU referred to all SCNP (total BrdU incorporation) and in small neuroblasts, defined as nestin-positive SCNP with a cell body diameter of ~15 µm and short neurite-like processes. Cultures treated with Wnt-3a and Wnt-3 up to 2DIV showed an increase of total BrdU incorporation of 68% and 71%, respectively, compared to controls (Fig. 1C) . Wnt-3a and Wnt-3 treatments also promoted BrdU incorporation in small neuroblasts by 19% and 20%, respectively, at 2DIV ( Fig. 1C) . At 4DIV, Wnt-3a still increased BrdU incorporation (total BrdU incorporation by 86% and BrdU incorporation in small neuroblasts by 63% compared to control; Fig 1C) . However, Wnt-3 did not affect BrdU incorporation (total or in small neuroblasts) compared to the control at 4DIV (Fig. 1C) . These results suggest that Wnt3a maintains SCNP in a proliferative state, whereas Wnt-3 stimulates their proliferation only transiently. To complement these findings, we performed real-time RT-PCR analysis of cyclindependent kinase (Cdk) inhibitors (p57/kip2 and p27/kip1) expression from 4DIV control, Wnt-3a-or Wnt-3-treated SCNPs. Wnt-3a significantly decreased the expression of p57 and p27 vs control, whereas Wnt-3 increased their expression levels vs control samples (Fig. 1D ). These findings are in agreement with the presence of putative TCF binding elements in the promoter region of the p57 and p27 (data not shown) and suggest that Wnt factors differently regulate SCNP proliferation/cell cycle exit at a transcriptional level.
Wnt-3 increases neurogenesis from SCNP by canonical Wnt/ß-catenin pathway
The transient increase in BrdU incorporation and the increased expression of Cdk inhibitors upon Wnt-3 stimulation suggested that SCNP exit the cell cycle after Wnt-3 treatment. Therefore we studied neurogenesis in Wnt-treated SCNP. Wnt-3 increased by approximately 40% the proportion of neurons (immunolabelled for the early neuronal marker ßIII-tubulin) referred to the total number of cells at 4DIV ( Fig. 2A , 2B and 4A), which also express the post-mitotic marker NeuU (Fig. 2D ). The percentage of ßIII-tubulin-immunoreactive neurons was not affected by Wnt-3a treatment ( Fig. 2A) , consistent with its effect inducing proliferation at 4DIV (Fig. 1C ).
In the canonical Wnt signaling, Wnt stimulation leads to GSK-3ß inhibition, β-catenin stabilization, nuclear translocation and transcriptional activation of TCF-target genes (Ciani and Salinas 2005) . Treatment with the selective GSK-3ß inhibitor Bio (Sato et al. 2004 ) increased the proportion of ßIII-tubulin-positive neurons (data not shown). To further investigate the implication of the canonical pathway, we studied the involvement 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 F o r P e e r R e v i e w 11 of β-catenin in the Wnt-induced neurogenesis by analyzing SCNP cultures expressing scrambled or β-catenin shRNAs. Wnt-3 but not Wnt-3a increased neurogenesis in SCNP expressing scrambled shRNA. Furthermore, the Wnt-3-dependent neurogenesis was blocked in SCNP expressing β-catenin shRNA (Fig. 2C) . These results suggest that Wnt-3 promotes neurogenesis through the canonical Wnt/ß-catenin in SCNP.
Wnt-3a and Wnt-3 increase neurite outgrowth of SCNP-derived neurons
When analyzing βIII-tubulin immunostained SCNP-derived neurons, we noticed an effect of Wnts in neurite development (Fig. 2D ). To investigate a role of Wnt-3a and Wnt-3 signaling on neurite outgrowth, we measured the length of all ßIII-tubulinpositive neurites. Wnt-3a increased total neurite length by 23% and 32% at 2DIV and 4DIV compared to the respective controls (Fig. 3A, 3C) . Similarly, Wnt-3 also increased neurite length by about 25% and 59% at 2DIV and 4DIV, respectively, compared to the controls (Fig. 3B, 3D ). These results demonstrate that Wnt-3a and Wnt-3 signaling stimulate neurite outgrowth in SCNP-derived neurons.
Next we inhibited Wnt signaling using the Wnt inhibitor Frizzled-8 cysteine-richdomain/Fc chimera (Fz-8/Fc) that prevents Wnt binding to the Frizzled-LRP5/6 receptor complex (Dann et al. 2001; Hsieh et al. 1999) , and Dikkopf-1 (Dkk-1) that binds to canonical Wnt co-receptors LRP5/6 (Kikuchi et al. 2009 ). Treatment with Wnt3a and Fz-8/Fc with or without Dkk-1 did not modify neurogenesis above control levels in SCNP cultures (Fig. 4A) . However, the proportion of βIII-tubulin-positive neurons following treatment with Wnt-3 and Fz-8/Fc or Wnt-3, Fz-8/Fc and Dkk-1 decreased compared to that of Wnt-3-stimulated cultures (Fig. 4A) (Fig. 4B ). These results demonstrate the specificity of the effects promoted by Wnt-3a and Wnt-3 CM.
GSK-3ß inhibition from plating or on established cultures differently affects neurite outgrowth
To dissect the signaling pathway through which Wnt-3a and Wnt-3 promote neurite outgrowth in SCNP cultures, we first investigated the consequences of inhibiting GSK-3ß. SCNP-derived neurons treated with the selective GSK-3ß inhibitor Bio (Sato et al. 2004) or Kenpaullone that inhibits GSK-3ß, Cdks and other kinases (Bain et al. 2003) from 2DIV to 3DIV showed an increased total neurite length of 23% and 26%, respectively, compared to control ( 22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 (Purro et al. 2008) . To study the requirement of ß-catenin in the Wnt-induced neurite outgrowth, SCNP cultures were transduced with lentivirus for the expression of ß-catenin shRNAs. We obtained a reduction of ß-catenin total levels of ~20-30% with shRNA1-2 after 5DIV (Fig. 6A) . Wnt-3a and Wnt-3 induced neurite outgrowth in SCNP expressing scrambled shRNA. However, the Wnt-induced neurite outgrowth was prevented in neurons expressing ß-catenin shRNAs (Fig. 6B-5C ), indicating that ß-catenin is required for the neurite extension induced by Wnt-3a and Wnt-3 in SCNP-derived neurons.
To study the involvement of gene transcription in the neurite outgrowth promoted by Wnt-3a and Wnt-3 we treated SCNP cultures with ActD. We used a concentration of ActD that did not affect neurite outgrowth in control neurons (Fig. 7A) . However, the neurite outgrowth induced by Wnt-3a and Wnt-3 was blocked in ActD-treated cultures (Fig. 7A) . We previously showed that ∆N-TCF4, which promoter can not bind ß-catenin (Roose et al. 1999) , blocks the axon outgrowth induced by Wnt-3a in hippocampal neurons (David et al. 2008) . We tested whether expression of dominant negative ∆N-TCF4 could block the neurite outgrowth induced by Wnt-3a and Wnt-3. SCNP expressing EGFP treated with Wnt-3a or Wnt-3 for 48h displayed neurites ~ 30% longer than untreated controls (Fig. 7B) . However, expression of ∆N-TCF4 blocked the increase in neurite length induced by Wnt-3a and Wnt-3 (Fig. 7B ). These results demonstrate that transcription by TCF4 is downstream of ß-catenin in the stimulation of neurite outgrowth induced by Wnt-3a and Wnt-3 in spinal neurons. 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Andersson et al. 2008; Castelo-Branco et al. 2003; Ciani and Salinas 2005; Chojnacki et al. 2009; Hirabayashi et al. 2004; Hirsch et al. 2007; Krylova et al. 2002; Kuwabara et al. 2009; Lee et al. 2004; Lie et al. 2005; Lu et al. 2004; Michaelidis and Lie 2008; Muroyama et al. 2002; Muroyama et al. 2004; Sousa et al. 2009 ). Wnt-3 secreted by astrocytes regulates adult hippocampal neurogenesis through the Wnt/ß-catenin pathway (Lie et al. 2005 ). Contrary to Wnt-5a and Wnt-1 that increase neurogenesis, Wnt-3a enhances proliferation from embryonic midbrain 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 (Hirabayashi et al. 2004; Woodhead et al. 2006; Yu et al. 2008) . Recently, the proneural transcription factor NeuroD1 was identified as a novel Wnt target gene in adult neurogenesis (Kuwabara et al. 2009 ). Our results indicate that Wnt-3a and Wnt-3 differently regulate Cdk inhibitor expression at 4DIV to control proliferation/differentiation. One possibility is that Wnt-3a and Wnt-3 signaling use different transcriptional co-activators resulting in the activation of proliferation or differention programs (Miyabayashi et al. 2007 ).
The effects promoted by Wnt-3a and Wnt-3 CM were specific as they were inhibited by the Wnt antagonists Fz-8Fc and Dkk-1. However, the blockade of the Wnt-3-induced neurogenesis observed upon Fz-8Fc and Dkk-1 co-treatments was partial. Ryk cleavage and its intracellular C-terminal domain (ICD) translocation to the nucleus is required for (Lyu et al. 2008) . Ryk expression in the spinal cord (Kamitori et al. 2002) would support a similar role in the SCNP-derived neurogenesis promoted by Wnt-3. However, Ryk ICD was suggested to signal independent of ß-catenin (Lyu et al. 2008 ) and we show that Wnt-3-induced neurogenesis from SCNP is ß-catenin-dependent. The possible contribution of Ryk to the Wnt-3-induced neurogenesis at the spinal cord remains to be studied.
Which are the types of neurons generated by Wnt-3 signaling? SCNP differentiate into different neuron types according to the synthesis of different neurotransmitters (Kalyani et al. 1998 ). Recent studies demonstrate that Wnt signaling acts in coordination with Shh in the specification of ventral cell types at the neural tube Ulloa and Marti 2009; Yu et al. 2008) . Wnt signaling generates dorsal and V2 cell fates at the expense of motoneurons (Yu et al. 2008 ). However, floor plate expression of Wnt-4/5 specifically promotes median motor column motoneuron identity (Agalliu et al. 2009 ).
Dissection of the Wnt pathway activated by Wnt-3a/Wnt-3 in SCNP neurogenesis and neurite outgrowth implicates the Wnt/ß-catenin canonical pathway. GSK-3ß inhibitors mimicked Wnt-3 signaling as they stimulated neurite outgrowth on established cultures.
Nevertheless, inhibition of GSK-3ß upon cell plating decreased the average neurite length. These findings suggest divergent roles for GSK3ß at early vs late stages of neurite specifation and outgrowth, in agreement with GSK3ß function in neuronal polarity and axon formation (Garrido et al. 2007; Kim et al. 2006) . Furthermore, ß-catenin was required for the Wnt-3 induced neurogenesis and the neurite outgrowth induced by Wnt-3a and Wnt-3. Although total ß-catenin levels decreased ~30 % upon expression of ß-catenin shRNAs, the Wnt-induced effects were completely prevented. Wnts regulate neurite development during the establishment of neuronal connections (Ciani and Salinas 2005) . Wnt-3a increased neurite outgrowth in hippocampal, dorsal root ganglia and spinal neurons through TCF-driven gene transcription of target genes (present results) (David et al. 2008; Lu et al. 2004 ). Wnt-3 induces growth cone enlargement, axon branching and stops axon extension during the terminal differentiation of NT-3-dependent sensory axons (Krylova et al. 2002) . Wnt-3a and
Wnt-3 signal independent of ß-catenin and transcription during sensory axon remodeling (Purro et al. 2008) . These findings contrast with the requirement of TCF4-driven transcription for the Wnt3a-and Wnt-3-dependent neurite outgrowth in spinal neurons. It is possible that, by activating different signaling pathways, Wnts induce different neurite behaviors (outgrowth or growth cone pausing/remodeling).
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